Increasing the Robustness of Biopharmaceutical Precipitation Assays - Part I: Derivative UV Spectrophotometric Method Development for in-line Measurements. 2022

Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
Merck KGaA, Frankfurter Strasse 250, Darmstadt, Germany.

In vitro precipitation assays are often applied to support drug and formulation development. Current methods applied to quantify the amount of dissolved drug, in particular (U)HPLC, require time-consuming sample preparation. Furthermore, small precipitates formed during the nucleation phase may not be removed quantitatively by filtration or centrifugation of the sample. Given the drawbacks of standard (U)HPLC analyses during the application in transfer experiments, it was the aim of this work to develop a robust and simple to implement in-line UV spectrophotometric method which accurately reflects the precipitation profile obtained from in vitro transfer assays. Based on the three model compounds cinnarizine, dipyridamole, and ketoconazole, the manuscript describes the development of a design of experiments (DoE) based approach to develop derivative UV spectrophotometric methods accounting for the change in media composition over time due to the dilution of simulated intestinal with simulated gastric fluid. An R script was developed which automatically identifies suitable wavelengths for in-line measurements. As an outcome of this study, a fast, robust, accurate, and specific derivative UV spectrophotometric methodology for measuring the concentration of dissolved drugs in in vitro transfer experiments was successfully developed. This method can flexibly be applied to multi-compartmental precipitation assays.

UI MeSH Term Description Entries
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
October 2003, Biopharmaceutics & drug disposition,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
January 2001, Journal of pharmaceutical and biomedical analysis,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
January 2013, Acta chimica Slovenica,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
April 2003, Journal of pharmaceutical and biomedical analysis,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
November 1989, Farmaco (Societa chimica italiana : 1989),
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
October 1995, Environmental monitoring and assessment,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
December 2000, Journal of pharmaceutical and biomedical analysis,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
September 2003, Journal of pharmaceutical and biomedical analysis,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
April 2005, Die Pharmazie,
Andreas Lehmann, and Katharina Krollik, and Kristian Beran, and Carina Hirtreiter, and Holger Kubas, and Christian Wagner
February 2000, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!